Danaher controls more than 98% of Nobel Biocare and started squeeze out procedure

Nobel Biocare applied for delisting

21-Jan-2015 - Sweden

Nobel Biocare Holding AG has been informed that Danaher Corporation filed a petition with the Commercial Court of the Canton of Zurich for the annulation (Kraftloserklärung) of the remaining publicly held registered shares of Nobel Biocare against payment of the offer price that had been offered and paid by Danaher in its public tender offer for all publicly held registered shares of Nobel Biocare.
 
Also, Nobel Biocare filed petitions with SIX Swiss Exchange for the de-listing (Dekotierung) of the registered shares of Nobel Biocare from SIX Swiss Exchange and for exemptions from certain obligations under the Listing Rules of SIX Swiss Exchange, including in particular from certain publicity obligations.

Danaher's intentions with respect to these petitions had been disclosed and announced in its public tender offer documents.

Other news from the department business & finance

Most read news

More news from our other portals

Is artificial intelligence revolutionizing the life sciences?